Skip to main content
. 2017 Jun 3;8(26):41841–41853. doi: 10.18632/oncotarget.18360

Figure 2. Survival percentages of mice from Figure 1.

Figure 2

Mice were s.c. injected with 5×105 B16ova cells and i.p. injected with 400μg anti-CTLA4 or IgG control antibody every 3rd day from day 0 until day 18. The data shown are pooled from two independent experiments (n = 6-7 per group).